VALTAMOX-CV

VALTAMOX-CV

Cracks Resistance - Enhances Performance

• Co-AmoxiClav demonstrated a higher efficacy rate than Cefixime and Ciprofloxacin.

• Clinical success rates Cefpodoxime-proxetil group 92.3%.

• Amoxicillin-clavulanic acid group 93.6%

• More effective than Cefaclor, Cefuroxime, Cephalexin.

• Higher efficacy rates than azithromycin in AECB.

• More effective than Azithromycin in bacterial AOM

• Better patient compliance

• Safe & effective for Children

• Offers cure rate of 95 % In UTI